tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Mirum Pharmaceuticals price target raised to $81 from $79 at Citizens JMP

Citizens JMP analyst Jonathan Wolleben raised the firm’s price target on Mirum Pharmaceuticals (MIRM) to $81 from $79 and keeps an Outperform rating on the shares. The company’s strong Q2 sales lead to a 2025 guidance increase, the analyst tells investors in a research note. The firm says Livmarli continues its strong launch.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1